Evaluation of Clinical Efficacy of AOIM â?? Z Tablets for Prevention of COVID â?? 19 Pandemic in High Risk Healthy Police Personnel â?? Single Arm, Open Labelled, Prospective Exploratory Interventional Clinical Study

Shree Dhootapapeshwar Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Healthy, Male or Female participants between the age group of 21 to years to 55 years (both inclusive).
•Healthy police personnel will be considered as those who do not have any acute medical condition or chronic medical/surgical condition that requires either immediate or continuous medical monitoring and treatment.
•2.Participants who are ready to provide written informed consent and who are ready to voluntarily participate and abide to the protocol requirements

•1.Pregnant and Lactating females
•2.Participants who have been quarantined or confirmed of having COVID-19 and have been isolated for its treatment. Participants having recently suffered and recovered of COVID-19 will also be excluded from the study
•3.Participants having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
•4.Participants having immune compromised status like HIV, Hepatitis, Tuberculosis and Cancer etc.
•5.Participants taking steroid treatment and or any kind of immunosuppressive therapy
•6.Participants participating in any other clinical study or having participated in any other study 3 months prior to screening in the present study.
•7.Other conditions, which in the opinion of the investigators makes the subject unsuitable for enrolment or could interfere in adherence to of the study protocol

发起方